SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 2,205.00
+115.00 (5.50%)
Last updated: Apr 24, 2026, 2:48 PM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 204.71 billion as of April 24, 2026. Its market cap has increased by 48.16% in one year.
Market Cap
204.71B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
16.10
Stock Price
2,205.00
Market Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 204.71B, an increase of 1,044.61%. That is a compound annual growth rate of 8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 204.71B | 42.16% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 205.42B |
| REYON Pharmaceutical | 204.87B |
| Jeil Pharmaceutical Co.,Ltd | 201.96B |
| AptaBio Therapeutics | 200.59B |
| JW Lifescience | 197.89B |
| Whan In Pharm | 197.22B |
| Hana Pharm | 173.29B |
| Daihan Pharmaceutical | 171.11B |